Brits feel far poorer now than they did at the start of 2025, with even high-income households downbeat about their financial prospects. In January, people were four per cent more …
Zara turns to AI-edited models amid shop closures
Zara is using artificial intelligence to edit images of human models for its e-commerce platforms, City AM understands, as the fast-fashion giant looks to cut costs amid a tough retail …
The Capitalist: City of London cracks down on public defecation
The City of London Corporation launches a festive anti-defecation campaign, City AM meets the King and BP does the hoedown throwdown; catch up on the latest City shenanigans in this …
Mark Kleinman: Corporates queue up for 2026 p(l)ay-date
Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column Corporates queue up for 2026 p(l)ay-date Talk about being on the …
Mark Kleinman: Corporates queue up for 2026 p(l)ay-date
Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column Corporates queue up for 2026 p(l)ay-date Talk about being on the …
Mark Kleinman: Corporates queue up for 2026 p(l)ay-date
Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column Corporates queue up for 2026 p(l)ay-date Talk about being on the …
For Starmer, things can only get worse
It’s been a bad year for Starmer, characterised by scandals, economic woes and plummeting poll ratings – and it looks 2026 is going to be no better, says Tom Harwood …
For Starmer, things can only get worse
It’s been a bad year for Starmer, characterised by scandals, economic woes and plummeting poll ratings – and it looks 2026 is going to be no better, says Tom Harwood …
For Starmer, things can only get worse
It’s been a bad year for Starmer, characterised by scandals, economic woes and plummeting poll ratings – and it looks 2026 is going to be no better, says Tom Harwood …
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a …